MED22 and lipoprotein glomerulopathy: Vacuole-like structures in podocytes, reminding of the phenotype in our pod-Med22 mice, have been reported in common human glomerulopathies19,20, and therefore, it is possible that Med22 has a role even in human glomerulopathies.